25 January 2019 - The Australian Government will make two new medicines for the treatment of the skin condition psoriasis more affordable, saving patients up to $32,600 per year.
The Liberal National Government will make two new medicines for the treatment of the skin condition psoriasis more affordable, saving patients up to $32,600 per year.
The medicine Tremfya (guselkumab) is being listed on the Pharmaceutical Benefits Scheme from February 1 for the treatment of severe chronic plaque psoriasis.